PortfolioBuzz: Create watchlist to track major constituents of #Nasdaq 100 $RDS $BP $AZN https://t.co/0sSuOhnviO https://t.co/sB0vRVMzg9
PortfolioBuzz: Get tweets in 1 watchlist for Social Media stocks $RDS $BP $AZN https://t.co/u6cMrb9LB7 https://t.co/teC1IqkTbf
RT @Datamonitor_JA: Opdivo looks to be first PD-L1 to gain approval in gastric cancer $BMY $MRK $RHHBY $AZN https://t.co/RRyUDiGPLW
RT @AndyBiotech: $AZN discontinues its Anti-CD19 in DLBCL and Anti-ANG2 in solid tumors.
$JUNO $KITE $SGEN $XNCR https://t.co/Ilrk3sSEGq
#AstraZeneca AZ slows durvalumab's development path in SCCHN. Read more: https://t.co/dgNsGgRVTQ $AZN
RT @pharma_sector: #AstraZeneca Drops Early Filing Plans for Cancer Drug. Read more: https://t.co/4PVA69eV29 $AZN
#AstraZeneca Drops Early Filing Plans for Cancer Drug. Read more: https://t.co/4PVA69eV29 $AZN
RT @CFAMBAibk: .. $aceyy $nobg 7 $SIE $ZURN $Azn $Con $Dte $Ng $enel $lr $rtl\ $zap $map $aeg $atc $g $engi $itv $pah3 $ale $lxs/ $auto $sz…
RT @AndyBiotech: $AZN discontinues its Anti-CD19 in DLBCL and Anti-ANG2 in solid tumors.
$JUNO $KITE $SGEN $XNCR https://t.co/Ilrk3sSEGq
Astrazeneca PLC $AZN Receives Buy Rating from Cantor Fitzgerald https://t.co/TZSzv7Rlvl
RT @AndyBiotech: $AZN Q3 setbacks
- Acalabrutinib filing pushed back to 1H17
- Gives up on durva HNSCC early filing plan
- Durva+treme H…
#AstraZeneca City News: Halfords, Bovis, Superdry & Astrazeneca. Read more: https://t.co/LLrf3f0Rf9 $AZN
Astrazeneca PLC $AZN Receives Buy Rating from Cantor Fitzgerald https://t.co/H4dSc5iD5D
$AZN 4day/20min chart: I look for the unusual and bet on it. Check out Last 10min volume prior to last 5 days. Macd… https://t.co/wCxutfPnVh
Astrazeneca PLC's buy rating reiterated at Cantor Fitzgerald. https://t.co/5lx7bucblw $AZN #AZN
Astrazeneca PLC's buy rating reiterated at Cantor Fitzgerald. https://t.co/j5NuxVzzv1 $AZN #AZN
RT @TalkMarkets: Everything Is Soaring As #Trump Makes Buying Stuff Great Again $AZN $BX $GS $VIV $SPY $DAX https://t.co/nogcQQhzlF
Research Analysts’ Recent Ratings Changes for Astrazeneca PLC $AZN https://t.co/rYWioYUuuh
.. $aceyy $nobg 7 $SIE $ZURN $Azn $Con $Dte $Ng $enel $lr $rtl\ $zap $map $aeg $atc $g $engi $itv $pah3 $ale $lxs/ $auto $szg $gctay $get)..
AstraZeneca boss spies opportunities from Trump and Brexit $azn https://t.co/LLzKmwsPfG
Everything Is Soaring As #Trump Makes Buying Stuff Great Again $AZN $BX $GS $VIV $SPY $DAX https://t.co/nogcQQhzlF
RT @AstraZeneca: Soriot: AZ is approaching an inflection point of a pipeline designed to transform our company and the lives of patients $A…
RT @JacobPlieth: $AZN confirms Mystic (1L NSCLC) & Arctic (3L NSCLC) durvalumab+treme readouts expected in H1 2017; filing in H2 2017
Astrazeneca PLC $AZN Issues Quarterly Earnings Results https://t.co/cX5e2z2Xcr
AstraZeneca plc's PT cut by Jefferies Group to GBX 5,600. buy rating. https://t.co/H4QdvQ1nZx $AZN #AZN
AstraZeneca plc's buy rating reiterated at Deutsche Bank AG. https://t.co/jOq01hQM2N $AZN #AZN
AstraZeneca plc's PT cut by Jefferies Group to GBX 5,600. buy rating. https://t.co/P6NtOzubWn $AZN #AZN
AstraZeneca plc's buy rating reiterated at Deutsche Bank AG. https://t.co/22ojipZ7Fa $AZN #AZN
Why These Stocks Were Down https://t.co/VO4a6wffxO $WUBA $ALXN $AXL $ANTH $AZN $AVID $BVX $CPTA $PMTS
#AstraZeneca sees profits fall by more than a quarter as rivals challenge leading drug
... Read more: https://t.co/HoZgmY1QIK $AZN
AstraZeneca plc's hold rating reiterated at HSBC. GBX 4,700 PT. https://t.co/YJeZ8mhCkP $AZN #AZN
AstraZeneca plc's neutral rating reiterated at JPMorgan Chase & Co.. https://t.co/SaM46Xc4Ve $AZN #AZN
AstraZeneca plc's hold rating reiterated at Beaufort Securities. https://t.co/PXTcxyGnaw $AZN #AZN
AstraZeneca plc's hold rating reiterated at HSBC. GBX 4,700 PT. https://t.co/z9hqSz9Cg9 $AZN #AZN
AstraZeneca plc's neutral rating reiterated at JPMorgan Chase & Co.. https://t.co/u3gf3vCtvx $AZN #AZN
AstraZeneca plc's hold rating reiterated at Beaufort Securities. https://t.co/ti4ObcwJrE $AZN #AZN
Drug firm #AstraZeneca sees 3rd quarter earnings fall 12 pct. Read more: https://t.co/XD0TKxFlJw $AZN
RT @conkers3: .@AstraZeneca 2/2) View our pipeline here: https://t.co/KxjsZEingC #BIOTECH #PHARMA #DRIP #QARP #INVESTING $AZN #AZN-1% £45.1…
Why These Stocks Were Down https://t.co/VO4a6wffxO $WUBA $ALXN $AXL $ANTH $AZN $AVID $BVX $CPTA $PMTS
$AZN AstraZeneca announces two new Phase IIIb trials for Forxiga in chronic kidney disease and chronic heart ... https://t.co/GsgCccD4OS
$AZN AstraZeneca to present anifrolumab lupus data at Annual European Congress of Rheumatology (EULAR 2016) https://t.co/Iewk6vwlo5
$AZN AstraZeneca receives approval in the EU for Qtern (saxagliptin and dapagliflozin) for treatment of type-... https://t.co/Q6RtywT0ED
$AZN Phase III combination trial of Bydureon and Forxiga shows significant benefits in patients with type-2 d... https://t.co/0SzGOjMLld
$AZN AstraZeneca presents further evidence for the potential of AZD9291 in first-line and pre-treated non-sma... https://t.co/fIYb4cPu1L
$AZN Tagrisso (osimertinib) shows clinical activity in patients with leptomeningeal disease from lung cancer https://t.co/6pmkiMLsuJ
$AZN AstraZeneca presents advances in oncology research at ECC 2015 with data on AZD9291, durvalumab and LYNP... https://t.co/13DrHFUsih
$AZN Lynparza (olaparib): latest data suggest potential overall survival advantage in patients with platinum ... https://t.co/antDLJKI9z
$AZN SOCRATES trial results for Brilinta/Brilique presented at European Stroke Organisation Conference https://t.co/cLnhlCjXhd
$AZN AstraZeneca presents positive Tagrisso (osimertinib) follow-up data in lung cancer at ELCC 2016 https://t.co/RncRv80QQZ
$AZN Positive CHMP opinion in EU for saxa/dapa (saxagliptin and dapagliflozin) for adults with type-2 diabetes https://t.co/0Im8LU0qNc
#AstraZeneca share price: Jefferies retains bullish stance on pharmco. Read more: https://t.co/y1x3kkTxL5 $AZN
RT @Trading_Direkt: Tobbe-analyser i dag:$ssab, $hm, $telia, $azn, $eric, $sand, $bol, $secu, $ori, $etx, $vws, $star, $evo, $pdx m fl
ht…
MyAllies Trading: $AZN AstraZeneca presents advances in oncology research at ECC 2015 with data on…… https://t.co/xpYiKIruhX
Tobbe-analyser i dag:$ssab, $hm, $telia, $azn, $eric, $sand, $bol, $secu, $ori, $etx, $vws, $star, $evo, $pdx m fl
https://t.co/P7d6ooqhwK
Here's Why AstraZeneca Dipped 14.2% in October: https://t.co/j55CCJzm0t $AZN
#FTSE100 won't be immune if #Trump sets more #protectionist tone to global #trade, particularly w. #China. $RDSA, $BP, $GSK, $AZN, $ULVR (5)
#FTSE100 won't be immune if #Trump sets more #protectionist tone to global #trade, particularly w. #China. $RDSA, $BP, $GSK, $AZN, $ULVR (5)
RT @Trading_Direkt: Tobbe-analyser i dag:$ssab, $hm, $telia, $azn, $eric, $sand, $bol, $secu, $ori, $etx, $vws, $star, $evo, $pdx m fl
ht…
Biotech Trade Alerts Archive -2016-11-10- $DMTX, $BMY, $ANTH, $TENX, $AZN, $PFE https://t.co/3proTZjm2j
https://t.co/G9pMgSr1JY < Review of this fantastic traders teaching service. Try it for FREE...$STX $ABX $ACAD $AZN
$AZN Announces Study Results Show SYMBICORT Improves Lung Function in Pediatric Asthma Patients https://t.co/f6eKnPssgl
#AstraZeneca Announces Study Results Show SYMBICORT Improves Lung Function in Pediatric Asth... Read more: https://t.co/aCxV7KcMYW $AZN
Wall Street Breakfast: Alibaba Can't Find Its Match https://t.co/rX1RKq281A $SPY $QQQ $AAPL $AMZN $AZN $AZSEY $BABA $CHAT $DIS $FIT $JWN
$AZN AstraZeneca Announces Study Results Show SYMBICORT Improves Lung Function in Pediatric Asthma Patien... - https://t.co/Ye8hjyOEt1
RT @marketexclusive: AstraZeneca plc (ADR) (NYSE:AZN) Retreats On Some Durvalumab Plans https://t.co/pVXFGbFXhP $AZN $ADR
RT @marketexclusive: AstraZeneca plc (ADR) (NYSE:AZN) Retreats On Some Durvalumab Plans https://t.co/pVXFGbFXhP $AZN $ADR
RT @marketexclusive: AstraZeneca plc (ADR) (NYSE:AZN) Retreats On Some Durvalumab Plans https://t.co/pVXFGbFXhP $AZN $ADR
RT @marketexclusive: AstraZeneca plc (ADR) (NYSE:AZN) Retreats On Some Durvalumab Plans https://t.co/pVXFGbFXhP $AZN $ADR
Astrazeneca PLC's neutral rating reiterated at JPMorgan Chase & Co.. https://t.co/HJYsFiqifj $AZN #AZN
Astrazeneca PLC's buy rating reiterated at Deutsche Bank AG. https://t.co/kLolb5qbZ4 $AZN #AZN
Astrazeneca PLC's hold rating reiterated at Beaufort Securities. https://t.co/9me8vO4IQG $AZN #AZN
RT @marketexclusive: AstraZeneca plc (ADR) (NYSE:AZN) Retreats On Some Durvalumab Plans https://t.co/pVXFGbFXhP $AZN $ADR
RT @marketexclusive: AstraZeneca plc (ADR) (NYSE:AZN) Retreats On Some Durvalumab Plans https://t.co/pVXFGbFXhP $AZN $ADR
RT @marketexclusive: AstraZeneca plc (ADR) (NYSE:AZN) Retreats On Some Durvalumab Plans https://t.co/pVXFGbFXhP $AZN $ADR
AstraZeneca plc (ADR) (NYSE:AZN) Retreats On Some Durvalumab Plans https://t.co/pVXFGbFXhP $AZN $ADR
AstraZeneca plc given GBX 4,000 PT by Goldman Sachs Group Inc.. sell rating. https://t.co/WxvLhwT6Pw $AZN #AZN
AstraZeneca plc given GBX 4,000 PT by Goldman Sachs Group Inc.. sell rating. https://t.co/wQpYUl2eOV $AZN #AZN
Astrazeneca PLC’s $AZN Buy Rating Reaffirmed at Deutsche Bank AG https://t.co/3w6S4HTWdb
Astrazeneca PLC $AZN Receives “Neutral” Rating from JPMorgan Chase & Co. https://t.co/tuRYu6ujGS
Astrazeneca PLC’s $AZN “Buy” Rating Reiterated at Citigroup Inc. https://t.co/0zHU1pWFDp
SAlphaTrending: Wall Street Breakfast: Alibaba Can't Find Its Match https://t.co/HcuV8zWUcq $SPY $QQQ $AAPL $AMZN $AZN $AZSEY $BABA $CHAT …
Astrazeneca PLC $AZN Stock Rating Reaffirmed by Beaufort Securities https://t.co/LM7ca6S7hf
Astrazeneca PLC $AZN Receives “Neutral” Rating from JPMorgan Chase & Co. https://t.co/PRHgihZOWn
#AstraZeneca: SYMBICORT Improves Lung Function In Pediatric Asthma Patients. Read more: https://t.co/LQXSOV0wsK $AZN
RT @pharma_sector: #AstraZeneca SYMBICORT Improves Lung Function In Pediatric Asthma Patients. Read more: https://t.co/RuhvN7axbD $AZN
Wall Street Breakfast: Alibaba Can't Find Its Match https://t.co/OZRkV6EGfU $SPY $QQQ $AAPL $AMZN $AZN $AZSEY $BABA $CHAT $DIS $FIT $JWN